# AMN Healthcare Services Inc: Form 10-Q for the period ended Sep 30, 2013

- Company: [AMN Healthcare Services Inc](/companies/amn.md) (CIK 1142750)
- Form: 10-Q
- Filed: 2013-11-01
- Accepted by EDGAR: Nov 1, 2013, 14:29 ET
- Period: 2013-09-30
- Accession: 0001142750-13-000010
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1142750/000114275013000010/ahs-20130930x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1142750/000114275013000010/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-07-01 to 2013-09-30 | $257.1m | us-gaap:Revenues |
| Revenue | 9 months, 2013-01-01 to 2013-09-30 | $763.2m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2013-07-01 to 2013-09-30 | $181.4m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2013-01-01 to 2013-09-30 | $540.1m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2013-07-01 to 2013-09-30 | $75.7m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2013-01-01 to 2013-09-30 | $223.1m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2013-07-01 to 2013-09-30 | $55.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2013-01-01 to 2013-09-30 | $163.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2013-07-01 to 2013-09-30 | $16.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2013-01-01 to 2013-09-30 | $49.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2013-07-01 to 2013-09-30 | $1.8m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2013-01-01 to 2013-09-30 | $7.8m | us-gaap:InterestExpense |
| Income tax | 3 months, 2013-07-01 to 2013-09-30 | $6.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2013-01-01 to 2013-09-30 | $17.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2013-07-01 to 2013-09-30 | $8.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2013-01-01 to 2013-09-30 | $24.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2013-07-01 to 2013-09-30 | $0.18 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2013-01-01 to 2013-09-30 | $0.51 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2013-07-01 to 2013-09-30 | $0.19 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2013-01-01 to 2013-09-30 | $0.53 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2013-07-01 to 2013-09-30 | 47,810,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2013-01-01 to 2013-09-30 | 47,776,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2013-01-01 to 2013-09-30 | $43.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2013-01-01 to 2013-09-30 | $6.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2013-09-30 | $31.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-09-30 | $226.3m | us-gaap:AssetsCurrent |
| Total assets | at 2013-09-30 | $544.2m | us-gaap:Assets |
| Current liabilities | at 2013-09-30 | $115.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2013-09-30 | $335.9m | us-gaap:Liabilities |
| Shareholders' equity | at 2013-09-30 | $208.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 35,882 characters.

The following discussion should be read in conjunction with our consolidated financial statements and the notes thereto and other financial information included elsewhere herein and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012, filed with the SEC on February 22, 2013 (“2012 Annual Report”). Certain statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” are “forward-looking statements.” See “Special Note Regarding Forward-Looking Statements.” We undertake no obligation to update the forward-looking statements in this Quarterly Report. References in this Quarterly Report to “AMN Healthcare,” the “Company,” “we,” “us” and “our” refer to AMN Healthcare Services, Inc. and its wholly owned subsidiaries.

### Overview

We are the innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. As an innovative workforce solutions partner, our managed services programs, recruitment process outsourcing, and placement of physicians, nurses and allied healthcare professionals into temporary and permanent positions enable our clients to successfully reduce complexity, increase efficiency and improve patient outcomes within the rapidly evolving healthcare environment. Our clients include acute and sub-acute care hospitals, government facilities, community health centers and clinics, physician practice groups, and several other healthcare-related settings. Our clients utilize our workforce solutions and healthcare staffing services to manage their temporary and permanent clinical workforce needs in an economically beneficial manner. Our managed services program enables healthcare organizations to increase their efficiency by managing all of their clinical supplemental workforce needs through one company.

We conduct business through three reportable segments: nurse and allied healthcare staffing, locum tenens staffing and physician permanent placement services. For the three months ended September 30, 2013, we recorded revenue of $257.1 million, as compared to $243.9 million for the same period last year. For the three months ended September 30, 2013, we recorded net income of $8.6 million, as compared to $5.9 million for the same period last year. For the nine months ended September 30, 2013, we recorded revenue of $763.2 million, as compared to $706.1 million for the same period last year. For the nine months ended September 30, 2013, we recorded net income of $24.6 million, as compared to $10.1 million for the same period last year.

Nurse and allied healthcare staffing segment revenue comprised 68% of total consolidated revenue for both the nine months ended September 30, 2013 and 2012. Through our nurse and allied healthcare staffing segment, we provide hospital and other healthcare facilities with a range of clinical workforce solutions, including: (1) a comprehensive managed services solution in which we manage all of the temporary nursing and allied staffing needs of a client; (2) traditional clinical staffing solutions of variable assignment lengths; and (3) a recruitment process outsourcing program that leverages our expertise and support systems to replace or complement a client’s existing internal recruitment function for permanent placement needs.

Locum tenens staffing segment revenue comprised 28% of total consolidated revenue for both the nine months ended September 30, 2013 and 2012. Through our locum tenens staffing segment, we place physicians of all specialties, as well as dentists, certified registered nurse anesthetists, physician assistants and nurse practitioners, with clients on a temporary basis as independent contractors. These locum tenens physicians and clinicians are used by our healthcare facility and physician practice group clients to fill temporary vacancies created by vacation and leave schedules and to bridge the gap while they seek permanent candidates or explore expansion. Our locum tenens clients represent a diverse group of healthcare organizations throughout the United States, including hospitals, medical groups, occupational medical clinics, individual practitioners, networks, psychiatric facilities, government institutions and managed care entities. The professionals we place are recruited nationwide and are typically placed on multi-week contracts with assignment lengths ranging from a few days up to one year. We also provide a comprehensive managed services solution in which we manage all of the locum tenens needs of a client.

Physician permanent placement services segment revenue comprised 4% of total consolidated revenue for both the nine months ended September 30, 2013 and 2012. Through our physician permanent placement services segment, we assist hospitals, healthcare facilities and physician practice groups throughout the United States in identifying and recruiting physicians for permanent placement. We perform the vast majority of our services on a retained basis, through our Merritt Hawkins® brand, for which we are generally paid through a blend of retained search fees and variable fees tied to work performed and successful placement. To a smaller degree, we also perform our services on a contingent basis, exclusively through our Kendall & Davis® brand, for which fees are paid once physician candidates are ultimately hired by our clients. Our broad specialty offerings include over 70 specialist and sub-specialist opportunities such as internal medicine, family practice and orthopedic surgery.

### Management Initiatives

Our growth strategy focuses on providing an innovative and differentiated value and experience to our clients, clinicians and physicians. To accomplish this, we have broadened our service offerings beyond our traditional core travel nurse and allied temporary staffing, locum tenens staffing, and physician permanent placement services, to include more strategic and recurring revenue sources from innovative workforce solutions offerings such as managed services programs and recruitment process outsourcing. Through these differentiated services, we have built strategic relationships with our clients to assist them in improving their financial, operational and patient care results through productivity and candidate quality enhancements. We continually seek strategic opportunities to expand into complementary service offerings that leverage our core capabilities of recruiting and credentialing clinicians and physicians, while providing a more recurring stream of revenues that reduces our exposure to economic cycle risk. At the same time, we continue to invest in our innovative workforce solutions, new candidate recruitment initiatives and technology infrastructure to ensure we are strategically ready in the long term to capitalize on the demand growth anticipated from the significant healthcare workforce shortages due to healthcare reform and the aging population.

### Recent Trends

While we are experiencing demand growth in our travel nursing division within certain specialties and for Electronic Medical Record ("EMR") engagements, overall demand is currently trending at levels consistent with prior year. Similarly, our allied business is experiencing growth within the imaging and lab specialties, but demand for therapy specialties has substantially decreased throughout the year. We believe the lack of demand growth is resulting from a combination of factors including weaker inpatient hospital admissions, reimbursement cuts, and tight spending controls from hospitals due to the uncertainty of near-term impacts from implementation of the Patient Protection and Affordable Care Act.

Our managed services program clients as well as our ability to shift our sales resources to other specialties have mitigated the financial impact of the reduced therapy demand. We continue to see clients migrate to managed service program relationships, and during the nine months ended September 30, 2013, revenue from these contracts represented approximately forty percent of our nurse and allied healthcare staffing business. As a result of these managed services relationships, we have an improved ability to fill more of the demand and create operational efficiencies. Although our gross margins have improved throughout the year, we are experiencing an increase in housing rent costs as a constrained rental market continues to drive rates higher. We have partially mitigated this impact by contracting with new lower cost rental properties and through bill rate increases.

In our locum tenens staffing segment, we are seeing strong market demand in our hospitalist, emergency medicine and advanced practice mid-level specialties, but continue to experience weaker demand in our radiology specialty. We are achieving improved bill rates and bill to pay spreads, but also experienced increased professional liability costs. We have added locum tenens to our managed services program offering, but adoption is in its very early stages.

Throughout the year, we have experienced increased demand for our services within our physician permanent placement services segment. We have also seen an increase in our recruiter productivity completing those searches, which has translated into improved profitability.

### Critical Accounting Policies and Estimates

Our critical accounting principles and estimates remain consistent with those reported in our 2012 Annual Report.

### Results of Operations

The following table sets forth, for the periods indicated, selected unaudited condensed consolidated statements of operations data as a percentage of revenue. Our results of operations include three reportable segments: (1) nurse and allied healthcare staffing; (2) locum tenens staffing; and (3) physician permanent placement services. Our historical results are not necessarily indicative of our future results of operations.

*Unaudited Condensed Consolidated Statements of Operations:*

|  | Three Months Ended September 30, 2013 | 2012 | Nine Months Ended September 30, 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of revenue | 70.6 | 71.5 | 70.8 | 71.7 |
| Gross profit | 29.4 | 28.5 | 29.2 | 28.3 |
| Selling, general and administrative | 21.6 | 21.5 | 21.5 | 21.2 |
| Depreciation and amortization | 1.3 | 1.4 | 1.3 | 1.5 |
| Income from operations | 6.5 | 5.6 | 6.4 | 5.6 |
| Interest expense, net | 0.7 | 1.5 | 1.0 | 3.3 |
| Income from continuing operations before income taxes | 5.8 | 4.1 | 5.4 | 2.3 |
| Income tax expense | 2.4 | 1.7 | 2.2 | 1.0 |
| Income from continuing operations | 3.4 | 2.4 | 3.2 | 1.3 |
| Income from discontinued operations, net of tax | 0.0 | 0.0 | 0.0 | 0.1 |
| Net income | 3.4% | 2.4% | 3.2% | 1.4% |

### Comparison of Results for the Three Months Ended September 30, 2013 to the Three Months Ended September 30, 2012

***Revenue.*** Revenue increased 5% to $257.1 million for the three months ended September 30, 2013 from $243.9 million for the same period in 2012, due to higher revenue in all three of our reportable segments.

Nurse and allied healthcare staffing segment revenue increased 3% to $171.0 million for the three months ended September 30, 2013 from $166.3 million for the same period in 2012. The increase was primarily driven by the increased volume of EMR engagements during the three months ended September 30, 2013, along with a combination of an increase in bill rates and a mix shift to higher bill rate specialties. The increases were partially offset by a slight decrease in the average number of clinicians on assignment, particularly in our allied and local staffing business lines, during the three months ended September 30, 2013.

Locum tenens staffing segment revenue increased 11% to $75.3 million for the three months ended September 30, 2013 from $67.6 million for the same period in 2012. The increase was primarily attributable to an 11% increase in the number of days filled during the three months ended September 30, 2013.

Physician permanent placement services segment revenue increased 9% to $10.9 million for the three months ended September 30, 2013 from $10.0 million for the same period in 2012. The increase was primarily due to the increase in active searches and placements during the three months ended September 30, 2013.

***Cost of Revenue.*** Cost of revenue increased 4% to $181.4 million for the three months ended September 30, 2013 from $174.3 million for the same period in 2012. The increase was primarily due to an increase in the number of days filled in the locum tenens staffing segment during the three months ended September 30, 2013, partially offset by lower healthcare professionals' insurance expenses.

Nurse and allied healthcare staffing segment cost of revenue increased 2% to $124.2 million for the three months ended September 30, 2013 from $122.3 million for the same period in 2012. The increase was primarily attributable to the increased volume of EMR engagements for the three months ended September 30, 2013, partially offset by lower healthcare professionals' insurance expenses.

Locum tenens staffing segment cost of revenue increased 10% to $53.2 million for the three months ended September 30, 2013 from $48.4 million for the same period in 2012. The increase was primarily attributable to an 11% increase in the number of days filled during the three months ended September 30, 2013.

Physician permanent placement services segment cost of revenue increased 13% to $4.1 million for the three months ended September 30, 2013 from $3.6 million for the same period in 2012 primarily due to increases in recruiter compensation.

***Gross Profit.*** Gross profit increased 9% to $75.7 million for the three months ended September 30, 2013 from $69.6 million for the same period in 2012, representing gross margins of 29.4% and 28.5%, respectively. The increase in consolidated gross margin was due to an increase in gross margin in the nurse and allied healthcare staffing and locum tenens staffing segments. The nurse and allied healthcare staffing segment increase was primarily due to a favorable mix shift to higher margin services and lower healthcare professionals' insurance expenses, and the locum tenens staffing segment improvement was primarily due to higher bill to pay spreads during the three months ended September 30, 2013. Gross margin by reportable segment for the three months ended September 30, 2013 and 2012 was 27.4% and 26.5% for nurse and allied healthcare staffing, 29.3% and 28.4% for locum tenens staffing, and 62.6% and 64.1% for physician permanent placement services, respectively.

***Selling, General and Administrative Expenses.*** Selling, general and administrative (“SG&A”) expenses were $55.6 million, representing 21.6% of revenue, for the three months ended September 30, 2013, as compared to $52.4 million, representing 21.5% of revenue, for the same period in 2012. The increase in SG&A expenses was due primarily to increased employee headcount, sales commissions and other costs related to supporting growth in the business. SG&A expenses broken down among the reportable segments, unallocated corporate overhead and share-based compensation are as follows:

|  | (In Thousands) Three Months Ended September 30, 2013 | 2012 |
| --- | ---: | ---: |
| Nurse and allied healthcare staffing | $26,395 | $25,212 |
| Locum tenens staffing | 14,519 | 12,890 |
| Physician permanent placement services | 4,609 | 4,197 |
| Unallocated corporate overhead | 8,595 | 8,507 |
| Share-based compensation | 1,487 | 1,569 |
|  | $55,605 | $52,375 |

***Depreciation and Amortization Expenses.*** Amortization expense was $1.6 million for both the three months ended September 30, 2013 and 2012. Depreciation expense decreased 6% to $1.7 million for the three months ended September 30, 2013 from $1.8 million for the same period in 2012, with the decrease primarily attributable to having more fixed assets fully depreciated during the three months ended September 30, 2013.

***Interest Expense, Net.*** Interest expense, net, was $1.8 million for the three months ended September 30, 2013 as compared to $3.7 million for the same period in 2012. The decrease was primarily attributable to a lower average debt outstanding balance and lower interest rate for the three months ended September 30, 2013.

***Income Tax Expense.*** Income tax expense was $6.3 million for the three months ended September 30, 2013 as compared to income tax expense of $4.2 million for the same period in 2012, reflecting effective income tax rates of 42.2% and 41.9% for these periods, respectively. The difference in the effective income tax rate was primarily attributable to the relationship of pre-tax income to permanent differences and the impact of provisions for uncertain tax positions.

### Comparison of Results for the Nine Months Ended September 30, 2013 to the Nine Months Ended September 30, 2012

***Revenue.*** Revenue increased 8% to $763.2 million for the nine months ended September 30, 2013 from $706.1 million for the same period in 2012, due to higher revenue in all three of our reportable segments.

Nurse and allied healthcare staffing segment revenue increased 8% to $517.9 million for the nine months ended September 30, 2013 from $478.8 million for the same period in 2012. The increase was primarily attributable to a 6% increase in the average number of clinicians on assignment, which was partially driven by the increased volume of EMR engagements during the period, with the remainder of the increase due primarily to a combination of an increase in bill rates and mix shift to higher bill rate specialties during the nine months ended September 30, 2013.

Locum tenens staffing segment revenue increased 7% to $213.4 million for the nine months ended September 30, 2013 from $198.7 million for the same period in 2012. The increase was primarily attributable to a 6% increase in the number of days filled and an increase in the average bill rate across most specialties during the nine months ended September 30, 2013.

Physician permanent placement services segment revenue increased 12% to $31.9 million for the nine months ended September 30, 2013 from $28.6 million for the same period in 2012. The increase was primarily due to the increase in active searches and placements during the nine months ended September 30, 2013.

***Cost of Revenue.*** Cost of revenue increased 7% to $540.1 million for the nine months ended September 30, 2013 from $506.3 million for the same period in 2012. The increase was primarily due to an increase in the average number of clinicians on assignment in the nurse and allied healthcare staffing segment and an increase in the number of days filled in the locum tenens staffing segment, partially offset by a $1.6 million actuarial-based workers compensation benefit recorded in the nurse and allied healthcare staffing segment during the nine months ended September 30, 2013.

Nurse and allied healthcare staffing segment cost of revenue increased 7% to $376.2 million for the nine months ended September 30, 2013 from $351.8 million for the same period in 2012. The increase was primarily attributable to a 6% increase in the average number of clinicians on assignment for the nine months ended September 30, 2013, partially offset by a $1.6 million actuarial-based workers compensation benefit.

Locum tenens staffing segment cost of revenue increased 6% to $152.0 million for the nine months ended September 30, 2013 from $143.4 million for the same period in 2012. The increase was primarily attributable to a 6% increase in the number of days filled for locum tenens providers.

Physician permanent placement services segment cost of revenue increased 8% to $11.9 million for the nine months ended September 30, 2013 from $11.1 million for the same period in 2012 primarily due to increases in recruiter compensation.

***Gross Profit.*** Gross profit increased 12% to $223.1 million for the nine months ended September 30, 2013 from $199.8 million for the same period in 2012, representing gross margins of 29.2% and 28.3%, respectively. The increase in consolidated gross margin was primarily due to an increase in gross margin in all three of our reportable segments. The nurse and allied healthcare staffing segment increase was primarily due to favorable insurance claims experience, the locum tenens staffing segment improvement was primarily due to higher bill to pay spreads and the physician permanent placement improvement was primarily due to improved revenue performance during the nine months ended September 30, 2013. Gross margin by reportable segment for the nine months ended September 30, 2013 and 2012 was 27.4% and 26.5% for nurse and allied healthcare staffing, 28.8% and 27.8% for locum tenens staffing, and 62.6% and 61.2% for physician permanent placement services, respectively.

***Selling, General and Administrative Expenses.*** SG&A expenses were $163.8 million, representing 21.5% of revenue, for the nine months ended September 30, 2013, as compared to $149.9 million, representing 21.2% of revenue, for the same period in 2012. The increase in SG&A expenses was due primarily to increased employee headcount, sales commissions and other costs related to supporting growth in the business, actuarial-based increases in professional liability reserves in our locum tenens staffing segment and a $2.0 million refund received from the California Employment Development Department during the nine months ended September 30, 2012 in connection with the settlement of a prior period assessment. The increases were partially offset by a $3.0 million gain on the holdback settlement in connection with the Medfinders acquisition during the nine months ended September 30, 2013. See additional information in “Item 1. Condensed Consolidated Financial Statements (Unaudited)—Notes to Unaudited Condensed Consolidated Financial Statements—Note 10, Treasury Stock.” SG&A expenses broken down among the reportable segments, unallocated corporate overhead and share-based compensation are as follows:

|  | (In Thousands) Nine Months Ended September 30, 2013 | 2012 |
| --- | ---: | ---: |
| Nurse and allied healthcare staffing | $78,682 | $72,698 |
| Locum tenens staffing | 44,102 | 38,459 |
| Physician permanent placement services | 13,227 | 11,705 |
| Unallocated corporate overhead | 23,085 | 22,418 |
| Share-based compensation | 4,667 | 4,575 |
|  | $163,763 | $149,855 |

***Depreciation and Amortization Expenses.*** Amortization expense decreased 6% to $4.8 million for the nine months ended September 30, 2013 from $5.1 million for the same period in 2012, with the decrease primarily attributable to having more intangible assets fully amortized during the nine months ended September 30, 2013. Depreciation expense decreased 11% to $5.0 million for the nine months ended September 30, 2013 from $5.6 million for the same period in 2012, with the decrease primarily attributable to having more fixed assets fully depreciated during the nine months ended September 30, 2013.

***Interest Expense, Net.*** Interest expense, net, was $7.8 million for the nine months ended September 30, 2013 as compared to $22.8 million for the same period in 2012. The decrease was primarily attributable to a $9.8 million loss on debt extinguishment recorded during the nine months ended September 30, 2012 and a lower average debt outstanding balance and lower interest rate for the nine months ended September 30, 2013.

***Income Tax Expense.*** We recorded an income tax expense from continuing operations of $17.1 million for the nine months ended September 30, 2013 as compared to $7.2 million for the same period in 2012, reflecting effective income tax rates of 41.0% and 43.8% for these periods, respectively. The difference in the effective income tax rate was primarily attributable to the relationship of pre-tax income to permanent differences. We currently estimate our annual effective income tax rate to be approximately 40.5% for 2013.

***Income From Discontinued Operations.*** We completed the sale of our home healthcare services segment in January 2012 and recorded its result of operations as discontinued operations for the nine months ended September 30, 2012. For the nine months ended September 30, 2012, income from discontinued operations of $0.8 million was comprised of a $1.2 million gain on sale, net of tax, and a $0.4 million loss from discontinued operations, net of tax. See additional information in “Item 1. Condensed Consolidated Financial Statements (Unaudited)—Notes to Unaudited Condensed Consolidated Financial Statements—Note 2, Discontinued Operations.”

### Liquidity and Capital Resources

In summary, our cash flows were:

|  | (In Thousands) Nine Months Ended September 30, 2013 | 2012 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $43,099 | $42,062 |
| Net cash (used in) provided by investing activities | (5,800) | 4,218 |
| Net cash used in financing activities | (11,308) | (46,354) |

Historically, our primary liquidity requirements have been for acquisitions, working capital requirements and debt service under our credit facilities. We have funded these requirements through internally generated cash flow and funds borrowed under our credit facilities. At September 30, 2013, $148.6 million of the Term Loan, net of discount, was outstanding under our Credit Facilities with $39.3 million of available credit under the Revolver.

We believe that cash generated from operations and available borrowings under the Revolver will be sufficient to fund our operations for the next 12 months and beyond. We intend to finance potential future acquisitions either with cash provided from operations, borrowing under the Revolver, bank loans, debt or equity offerings, or some combination of the foregoing. The following discussion provides further details of our liquidity and capital resources.

#### Operating Activities

Net cash provided by operations for the nine months ended September 30, 2013 was $43.1 million, compared to $42.1 million for the same period in 2012. The increase in net cash provided by operations was primarily attributable to better operating results during the nine months ended September 30, 2013, partially offset by the $14.7 million in tax payments. Our Days Sales Outstanding ("DSO") was 52 days at September 30, 2013. DSO was 53 days and 54 days at December 31, 2012 and September 30, 2012, respectively.

#### Investing Activities

Net cash used in investing activities for the nine months ended September 30, 2013 was $5.8 million, compared to net cash proceeds provided of $4.2 million for the same period in 2012. The change was primarily attributable to the (1) cash proceeds received from the sale of our home healthcare services segment during the nine months ended September 30, 2012 and (2) cash used during the nine months ended September 30, 2013 for additional capital expenditures to support the growth in the business and management initiatives.

#### Financing Activities

Net cash used in financing activities during the nine months ended September 30, 2013 was $11.3 million, primarily due to paying down our Term Loan during the period. Net cash used in financing activities during the nine months ended September 30, 2012 was $46.4 million, primarily due to paying down our debt and paying off prior credit facilities offset with the additional borrowings under the then-existing new credit facilities during the period.

#### Credit Agreement

Our Credit Agreement provides our two “Credit Facilities,” which include (A) the Revolver and (B) the Term Loan. The Credit Agreement provides that we may from time to time obtain an increase in the Revolver or the Term Loan in an aggregate principal amount not to exceed $75 million (with a $37.5 million sublimit for the Revolver) subject to, among other conditions, the arrangement of additional commitments with financial institutions reasonably acceptable to us and the administrative agent. The Revolver is available to us for working capital, capital expenditures, permitted acquisitions and general corporate purposes. The maturity dates of the Revolver and the Term Loan are April 5, 2017 and April 5, 2018, respectively. At September 30, 2013, the aggregate outstanding principal amount of the Term Loan, net of discount, was $148.6 million.

The Revolver carries an unused fee of 0.375% per annum. There are no mandatory reductions associated with the Revolver. There were no amounts outstanding under the Revolver at both September 30, 2013 and December 31, 2012.

The Term Loan is subject to amortization of principal of 1.00% per year of the original Term Loan amount, payable in equal quarterly installments. The voluntary prepayments we made during 2012 satisfied all scheduled quarterly principal amortization payments due under the Credit Facilities through the remaining term of the Credit Agreement.

The Credit Agreement contains various customary affirmative and negative covenants, including restrictions on assumption of additional indebtedness, declaration of dividends, dispositions of assets, consolidation into another entity, capital expenditures in excess of specified amounts and allowable investments. It also contains financial covenants that require us (1) not to exceed a certain maximum consolidated leverage ratio and (2) to maintain a minimum consolidated interest coverage ratio. We were in compliance with these requirements as of September 30, 2013.

We entered into the First Amendment, which became effective on April 9, 2013. For more detail regarding the terms of the First Amendment, please see “Item 1. Condensed Consolidated Financial Statements (Unaudited)—-Notes to Unaudited Condensed Consolidated Financial Statements—Note 8, Notes Payable and Related Credit Agreement.”

#### Letters of Credit

At September 30, 2013, we maintained outstanding standby letters of credit totaling $28.9 million as collateral in relation to our professional liability insurance agreements, workers compensation insurance agreements, and a corporate office lease agreement. Of the $28.9 million outstanding letters of credit, we have collateralized $18.2 million in cash, cash equivalents and investments and the remaining amounts are collateralized by the Revolver. Outstanding standby letters of credit at December 31, 2012 totaled $31.9 million.

### Off-Balance Sheet and Other Financing Arrangements

At September 30, 2013, we did not have any material relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance, variable interest or special purpose, which would have been established for the purpose of facilitating off-balance-sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts. As such, we are not materially exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships. We do not have any material relationships or transactions with persons or entities that derive benefits from their non-independent relationship with us or our related parties.

### Potential Fluctuations in Quarterly Results and Seasonality

Due to the regional and seasonal fluctuations in the hospital patient census and staffing needs of our clients and due to the seasonal preferences for destinations of our clinicians and physicians, revenue, earnings and the number of clinicians and physicians on assignment are subject to moderate seasonal fluctuations.

### Recent Accounting Pronouncements

There have been no new accounting pronouncements issued but not yet adopted that are expected to materially affect our consolidated financial condition or results of operations.

### Special Note Regarding Forward-Looking Statements

This Quarterly Report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We based these forward-looking statements on our expectations, estimates, forecasts and projections about future events and about the industry in which we operate. Forward-looking statements are identified by words such as “believe,” “anticipate,” “expect,” “intend,” “plan,” “will,” “should,” “would,” “project,” “may,” variations of such words and other similar expressions. In addition, any statements that refer to projections of financial items, anticipated growth, future growth and revenues, future economic conditions and performance, plans, objectives and strategies for future operations, expectations, or other characterizations of future events or circumstances are forward-looking statements. All forward-looking statements involve risks and uncertainties. Our actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Factors that could cause actual results to differ materially from those implied by the forward-looking statements in this Quarterly Report are set forth in our 2012 Annual Report and include but are not limited to:

- the effects of economic downturns or slow recoveries, which could result in less demand for our services;
- any inability on our part to maintain our clients and secure new ones and to fill new and profitable orders and searches for our clients;
- the level of consolidation and concentration of buyers of healthcare staffing services, which could affect the pricing of our services and our ability to mitigate risk;
- any inability on our part to quickly respond to changing marketplace conditions, such as alternative modes of healthcare delivery, or to client needs;
- the ability of our clients to retain and increase the productivity of their permanent staff, which may negatively affect the demand for our services;
- our ability to grow and operate our business in compliance with employment laws and other legislation, laws and regulations that may directly or indirectly affect us, such as Medicare certification and reimbursement, professional licensure, government contracting requirements, the Patient Protection and Affordable Care Act and other state or federal healthcare reform legislation;
- the challenge to the classification of certain of our healthcare professionals as independent contractors;
- the effect of medical malpractice, employment and wage regulation and other claims asserted against us, which could subject us to substantial liabilities;
- any inability on our part to implement new operating and back office systems effectively;
- the effect of technology disruptions and obsolescence, which may negatively affect our business operations;
- any inability on our part to recruit and retain sufficient quality clinicians and physicians at reasonable costs;
- any inability on our part to properly screen and match quality clinicians and physicians with suitable placements;
- any inability on our part to successfully attract and retain a sufficient number of quality sales and operational personnel;
- the loss of our key officers and management personnel;
- any inability on our part to maintain at reasonable costs the positive brand identities we have developed and acquired;
- any recognition by us of an impairment to goodwill or indefinite lived intangibles;
- the effect of adverse adjustments by us to accruals for self-insured retentions and uncertain income tax liability, which could decrease our earnings or increase our losses, as the case may be, or negatively affect our cash flow; and
- our level of indebtedness and any inability on our part to generate sufficient cash flow to service our debt.

## Market risk

As filed, 821 characters.

Market risk is the risk of loss arising from adverse changes in market rates and prices, such as interest rates, foreign currency exchange rates and commodity prices. During the nine months ended September 30, 2013, our primary exposure to market risk was interest rate risk associated with our debt instruments. We entered into the First Amendment to the Credit Agreement, which went into effect on April 9, 2013. Borrowings under the Term Loan bear interest at floating rates based upon either a LIBOR (with a floor of 0.75%) or a base rate option selected by us, plus a spread of 3.00% and 2.00%, respectively. A 1% change in interest rates on our variable rate debt would not have resulted in a material effect on our unaudited condensed consolidated financial statements for the nine months ended September 30, 2013.

## Controls and procedures

As filed, 1,206 characters.

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of September 30, 2013 were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 136 characters.

We do not believe that there has been any material changes from the risk factors disclosed in Part I, Item 1A of our 2012 Annual Report.

Filed Nov 1, 2013.
Source: SEC EDGAR, the filing index for accession 0001142750-13-000010. Last ingested by Listed: Nov 5, 2026, 17:59 ET. No prices; not investment advice.
